Summary & Overview
HCPCS G8635: Pharmacologic Therapy for Osteoporosis Not Prescribed
HCPCS Level II code G8635 documents that pharmacologic therapy for osteoporosis was not prescribed and no reason was provided. As a non-treatment documentation code, G8635 captures instances where a provider did not initiate medication for osteoporosis despite evaluation, which has implications for quality reporting, care coordination, and population health measurement. Nationally, consistent use of this code affects performance metrics related to osteoporosis management and may inform payer coverage reviews and quality programs.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The coverage discussion frames how documentation codes like G8635 interact with payer quality initiatives and claims adjudication.
Readers will learn the clinical context of the code, typical sites of service where it is used, and what to expect in claims processing and quality measurement when pharmacologic therapy is not prescribed. The publication also outlines available benchmarks and policy considerations relevant to documentation-only codes and summarizes where input data is missing. Data not available in the input.
Billing Code Overview
HCPCS Level II code G8635 indicates Pharmacologic therapy for osteoporosis was not prescribed, reason not given. This code documents that a patient with osteoporosis did not receive a prescription for pharmacologic treatment and that no specific reason for the omission was recorded.
-
Service type: Documentation of medication management decision (non-prescription) related to osteoporosis treatment
-
Typical site of service: Outpatient or ambulatory clinical settings where osteoporosis evaluation and treatment decisions are made, such as primary care clinics, specialty osteoporosis or endocrinology clinics, and other outpatient provider offices
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an older adult woman seen in primary care or endocrinology after a fragility fracture or after bone mineral density testing demonstrates osteoporosis (for example, T-score ≤ -2.5). The clinician documents the diagnosis of osteoporosis, counsels the patient about pharmacologic therapy (bisphosphonates, denosumab, teriparatide, romosozumab), and documents that pharmacologic therapy was not prescribed but does not record a specific reason. The clinical workflow includes history and medication review, assessment of fracture risk (FRAX or clinical risk factors), discussion of risks and benefits of treatment, documentation of non-prescription of therapy, and scheduling follow-up or alternative management (calcium/vitamin D optimization, fall risk mitigation, referral to bone health specialist). Typical sites of service are outpatient clinic (primary care, geriatric, endocrinology), specialty osteoporosis clinics, and post-fracture care coordination programs. Common patient characteristics include advanced age, comorbidities that may complicate therapy, recent fragility fracture, or patient preference not documented as a reason in the chart.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when documentation justifies substantially greater work than typical for the billed service (e.g., complex counseling and coordination around osteoporosis treatment decisions). |